Emcure Pharmaceuticals Ltd. benchmarking: Performance to industry peers

Financial

	Emcure Pharma	JB Chem & Pharma	Wockhardt
Operational Metrics
Pharmaceuticals
Domestic Sales Growth - YoY	1.4 %	10.1 %	10.6 %
US DMF Filings	102.0 .	n/a	n/a
R&D as a % of Total Sales	3.9 %	1.35 %	2.9 %
Financials
5 yr Average ROE	20.81 %	19.49 %	4.06 %
5yr average Equity Multiplier	2.6	1.52	2.02
5yr Average Asset Turnover Ratio	0.93	0.77	0.39
5yr Avg Net Profit Margin	8.56 %	16.71 %	-4.28 %
Price to Book	6.35	8.24	5.17
P/E	33.98	48.29	119.85
5yr Avg Cash Conversion Cycle	-8.5 Days	7.58 Days	-94.15 Days
Inventory Days	82.11 Days	50.33 Days	61.29 Days
Days Receivable	87.83 Days	67.54 Days	60.36 Days
Days Payable	177.06 Days	90.39 Days	251.45 Days
5yr Average Interest Coverage Ratio	5.19	58.81	-0.43
5yr Avg ROCE	27.53 %	23.05 %	-0.28 %
5yr Avg Operating Profit Margin	19.97 %	24.73 %	5.03 %
5 yr average Debt to Equity	0.76	0.07	0.56
5yr CAGR Net Profit	11.68 %	8.05 %	n/a
5yr Average Return on Assets	7.99 %	12.98 %	-1.79 %
Shareholdings
Promoter Holding	77.87 %	48.8 %	49.08 %
Share Pledged by Promoters	0.04 %	0.0	18.82 %
Change in Promoter Holding (3 Yrs)	-0.21 %	-5.13 %	-10.23 %
Change in Mutual Fund Holding (3 Yrs)	1.64 %	2.83 %	8.12 %

Business

	Emcure Pharma	JB Chem & Pharma	Wockhardt
Product Wise Break-Up	Product Wise Break-Up Formulations 95.73 API`s 4.27 CDMO 0 API 0 Formulation exported 0 Domestic formulation 0 Pharmaceuticals 0	Product Wise Break-Up Pharmaceuticals 0 Active Pharmaceutical Ingredient (API) 1.97 Formulations 28.73 Domestic Formulations 58.22 API`s 0 Formulations 0 Contract Manufacturing 10.99 Others 0.09	Product Wise Break-Up Pharmaceutical 100.0 API 0 Formulation exported 0 Domestic formulation 0 API`s 0 Formulations 0 CDMO 0
Product Wise Break-Up	Product Wise Break-Up Formulations 95.73 API`s 4.27 CDMO 0 API 0 Formulation exported 0 Domestic formulation 0 Pharmaceuticals 0	Product Wise Break-Up Pharmaceuticals 0 Active Pharmaceutical Ingredient (API) 1.97 Formulations 28.73 Domestic Formulations 58.22 API`s 0 Formulations 0 Contract Manufacturing 10.99 Others 0.09	Product Wise Break-Up Pharmaceutical 100.0 API 0 Formulation exported 0 Domestic formulation 0 API`s 0 Formulations 0 CDMO 0
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Cardiovascular 20.8 Gynecology 18.5 Anti-infectives 12.8 Pain and analgesics 7.1 Vitamins, minerals and nutrients 6.7 Blood-related 5.9 Oncology/Anti-neoplastics 5.4 Respiratory 5.1 HIV antivirals 4.5 Gastrointestinal 3.7 Anti-diabetic 2.9 Neurology/CNS 1.6 Hormones 0 Others 5.0	-	-
Location Wise Break-Up	Location Wise Break-Up India 43.38 Other continents 20.19 Europe 19.64 North America 16.8 Rest of the World 0 Russia 0 South Africa 0 USA 0	Location Wise Break-Up USA 0 North America 0 Russia 0 Other continents 0 India 57.91 Rest of the World 42.09 Europe 0 South Africa 0	Location Wise Break-Up USA 0 North America 0 Russia 0 Other continents 0 India 19.79 Rest of the World 36.17 Europe 0 South Africa 0 Others 44.04
Acute vs Chronic	Acute vs Chronic Chronic 52.87 Acute therapy 47.13	-	-
Asset Break-Up - Geography Wise	Asset Break-Up - Geography Wise India 97.98 North America 1.24 Other continents 0.78 Europe 0	-	-

Emcure Pharmaceuticals Ltd.

Emcure Pharmaceuticals Ltd.

Financial

Business

SIGN UP FOR FREE